The Current Role of Lymph Node Dissection in the Management of Renal Cell Carcinoma

Abstract EN

The role of lymph node dissection remains controversial in the surgical management of renal cell carcinoma.

Incidental renal masses are being diagnosed at increasing rates due to the routine use of CT scans.

Despite the increase in incidental diagnosis of renal masses, 20% to 30% of patients present with metastatic disease.

Currently, surgeons do not routinely perform lymph node dissection unless there is gross evidence of lymphadenopathy, as patients without clinical evidence of lymphadenopathy rarely have positive nodes at the time of surgery.

Patients with metastatic disease to the regional lymph nodes have a poor overall prognosis.

However, some evidence supports a therapeutic benefit of lymphadenectomy in these patients.

Further, the staging information gained from diagnosing lymph node involvement may allow for the use of new agents to treat metastatic disease and effect outcomes.